Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 24.51%69.08M | 22.60%328.92M | 20.75%110.23M | 49.29%97.61M | 5.92%65.61M | 11.69%55.48M | 77.74%268.29M | 91.29M | 65.38M | 61.94M |
| Cost of revenue | 23.98%59.27M | 27.54%279.36M | 39.54%96.72M | 38.80%80.48M | 5.56%54.35M | 18.75%47.81M | 70.07%219.04M | 69.32M | 57.98M | 51.49M |
| Gross profit | 27.82%9.81M | 0.66%49.57M | -38.54%13.5M | 131.53%17.13M | 7.68%11.25M | -18.52%7.68M | 122.39%49.24M | 21.97M | 7.4M | 10.45M |
| Operating expense | 6.83%3.52M | 15.08%13.32M | -74.39%2.99M | 39.97%4.25M | -30.04%3.47M | 68.85%3.3M | 41.07%11.58M | 11.68M | 3.04M | 4.96M |
| Selling and administrative expenses | 6.45%3.3M | 10.56%14.26M | 13.34%3.93M | 40.44%3.99M | -32.62%3.22M | 74.47%3.1M | 59.43%12.89M | --3.46M | --2.84M | --4.78M |
| -Selling and marketing expense | -4.62%62K | -2.03%366.89K | -11.11%136K | -16.49%81K | 46.27%98K | 14.04%65K | -2.95%374.49K | --153K | --97K | --67K |
| -General and administrative expense | 6.68%3.24M | 10.94%13.89M | 14.47%3.79M | 42.45%3.91M | -33.74%3.13M | 76.47%3.04M | 62.56%12.52M | --3.31M | --2.74M | --4.72M |
| Other operating expenses | 12.89%219K | 22.78%948.94K | -111.38%-935K | 33.16%261K | 38.12%250K | 11.49%194K | 25.50%772.9K | --8.21M | --196K | --181K |
| Total other operating income | --0 | -9.93%1.88M | ---- | ---- | --0 | --0 | 319.74%2.09M | ---- | ---- | --0 |
| Operating profit | 43.62%6.29M | -3.77%36.25M | 2.12%10.51M | 195.21%12.88M | 41.81%7.78M | -41.36%4.38M | 170.27%37.67M | 10.3M | 4.36M | 5.49M |
| Net non-operating interest income (expenses) | 52.21%-54K | -14.44%-339.75K | 92.59%-6K | -153.85%-132K | -4.17%-100K | -17.71%-113K | 20.08%-296.88K | -81K | -52K | -96K |
| Non-operating interest expense | -52.21%54K | 14.44%339.75K | -92.59%6K | 153.85%132K | 4.17%100K | 17.71%113K | -20.08%296.88K | --81K | --52K | --96K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 114.77%1.18M | -2,044.92%-7.99M | ||||||||
| Less:Write off | ---- | -114.77%-1.18M | ---- | ---- | ---- | ---- | 2,044.92%7.99M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 59.75%639K | -10.09%1.88M | 4.60%682K | 17.97%466K | 58.85%332K | -52.04%400K | 2.09M | 652K | 395K | 209K |
| Income before tax | 47.32%6.87M | 26.24%37.09M | 2.97%11.19M | 180.79%13.22M | 43.09%8.01M | -43.13%4.67M | 122.68%29.38M | 10.87M | 4.71M | 5.6M |
| Income tax | 51.79%1.7M | -8.78%9.19M | -25.90%2.83M | 63.90%3.16M | -13.42%2.02M | -43.83%1.12M | 179.61%10.07M | 3.82M | 1.93M | 2.33M |
| Net income | 45.91%5.17M | 44.51%27.9M | 18.62%8.36M | 261.89%10.06M | 83.44%5.99M | -42.91%3.55M | 101.29%19.3M | 7.05M | 2.78M | 3.27M |
| Net income continuous operations | 45.91%5.17M | 44.51%27.9M | 18.62%8.36M | 261.89%10.06M | 83.44%5.99M | -42.91%3.55M | 101.29%19.3M | --7.05M | --2.78M | --3.27M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 45.91%5.17M | 44.51%27.9M | 18.62%8.36M | 261.89%10.06M | 83.44%5.99M | -42.91%3.55M | 101.29%19.3M | 7.05M | 2.78M | 3.27M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 45.91%5.17M | 44.51%27.9M | 18.62%8.36M | 261.89%10.06M | 83.44%5.99M | -42.91%3.55M | 101.29%19.3M | 7.05M | 2.78M | 3.27M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 46.32%0.0139 | -6.48%0.075 | 18.42%0.0225 | 261.33%0.0271 | 82.95%0.0161 | -43.14%0.0095 | 210.88%0.0802 | 0.019 | 0.0075 | 0.0088 |
| Diluted earnings per share | 46.32%0.0139 | -6.48%0.075 | 18.42%0.0225 | 261.33%0.0271 | 82.95%0.0161 | -43.14%0.0095 | 210.88%0.0802 | 0.019 | 0.0075 | 0.0088 |
| Dividend per share | 0 | 0.013 | 0 | 0 | 0.013 | |||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.